Literature DB >> 33732891

Rare cause of cystic liver lesions: Liver metastasis of gastrointestinal stromal tumors.

Masahiro Sakata1, Toshihiko Kaneyoshi1, Takashi Fushimi1, Jiro Watanabe2.   

Abstract

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms of the gastrointestinal tract with an annual incidence of 1-2 per 10 000 people. Although most GISTs are solid, they may present with predominantly cystic components. A 69-year-old Japanese woman presented with a recently elevated gamma-glutamyl transpeptidase level. Computed tomography revealed multiple space-occupying lesions (SOLs) in the liver. These SOLs appear cystic on magnetic resonance imaging and abdominal ultrasound and are associated with thick walls at the margins. In addition, these thick walls showed high intensity on diffusion-weighted images. She was diagnosed with liver metastasis of GIST by diagnostic biopsies from the thick parts of the cystic liver lesion (thick walls at the margins). The primary lesion was thought to be located along the medial side of the descending part of the duodenum, but a duodenal biopsy was initially undiagnosed. Liver metastases due to GISTs are known to cause cystic changes after treatment, such as imatinib mesylate. However, to the best of our knowledge, only six cases where hepatic GIST with predominantly cystic changes (prior to any treatment) have been reported. It should be noted that GISTs appear cystic in all organs.
© 2021 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cystic lesion; gastrointestinal stromal tumor; liver metastasis

Year:  2021        PMID: 33732891      PMCID: PMC7936617          DOI: 10.1002/jgh3.12487

Source DB:  PubMed          Journal:  JGH Open        ISSN: 2397-9070


Introduction

Gastrointestinal stromal tumors (GISTs) are rare mesenchymal tumors of the gastrointestinal tract with an incidence of 1–2 per 10 000 people annually. The most common sites of occurrence are the stomach (59%), jejunum‐ileum intestine (29.2%), and duodenum (4.5%). The most common recurrence site of metastases is the liver (70–77%), and the rate of liver metastases in patients with a primary GIST was reportedly only 15.9%. Cystic changes may also be observed in hepatic tumors, either due to necrosis or cystic degeneration of rapidly growing hypervascular tumors or as a manifestation of mucinous colonic or ovarian adenocarcinomas. Although most GISTs are solid, they may present with predominantly cystic components.

Case report

A 69‐year‐old Japanese woman presented with a recently elevated gamma‐glutamyl transpeptidase level. Physical examination showed no symptoms or abnormalities. She had smoked 15 cigarettes daily for 45 years and had no history of alcohol consumption. Laboratory tests showed the following: white blood cell count, 7500/μL (neutrophils, 71.3%; eosinophils, 0.7%); C‐reactive protein level, 0.26 mg/dL; serum creatinine, 2.30 mg/dL; estimated glomerular filtration rate, 17 mL/min/1.73 m2; serum carcinoembryonic antigen level, 5.54 ng/mL; serum carbohydrate antigen 19‐9 level, 7.71 U/mL; serum alpha‐fetoprotein level, 4.81 ng/mL; and serum des‐gamma‐carboxy prothrombin level, 14 mAU/mL. Computed tomography (CT) revealed multiple space‐occupying lesions (SOLs) in the whole liver and a 9‐cm large lesion in the medial side of the descending part of the duodenum (Fig. 1a). Magnetic resonance imaging (MRI) revealed multiple cystic SOLs in the liver, showing high intensity on T2‐weighted images (Fig. 1b). Liver SOLs also appear cystic on abdominal ultrasound (US) and are associated with thick walls at the margins, as well as MRI (Fig. 1b,e). Color Doppler imaging of US revealed no signal flow at the thick parts of the cystic lesions. In addition, these thick walls and mass lesions in the vicinity of the duodenum showed high intensity on diffusion‐weighted images (Fig. 1c,d). Upper gastrointestinal endoscopy revealed an irregularly raised surface adjacent to the duodenal papilla (Fig. 1f).
Figure 1

(a) Plain computed tomography revealing multiple space‐occupying lesions (SOLs) in the liver (blue arrows). The densities of the central cystic area and marginal thickening area are 20 Hounsfield unit (HU) and 40 HU, respectively. (b) A 9‐cm large lesion in the medial side of the descending part of the duodenum (yellow arrows). (c) Magnetic resonance imaging revealing multiple cystic SOLs in the liver that showed high intensity on T2‐weighted images. (c,d) These thick walls and mass lesions in the vicinity of the duodenum show high intensity on diffusion‐weighted images. (e) Liver SOLs also appear cystic on abdominal ultrasound. (f) Upper gastrointestinal endoscopy revealing an irregularly raised surface near the duodenal papilla.

(a) Plain computed tomography revealing multiple space‐occupying lesions (SOLs) in the liver (blue arrows). The densities of the central cystic area and marginal thickening area are 20 Hounsfield unit (HU) and 40 HU, respectively. (b) A 9‐cm large lesion in the medial side of the descending part of the duodenum (yellow arrows). (c) Magnetic resonance imaging revealing multiple cystic SOLs in the liver that showed high intensity on T2‐weighted images. (c,d) These thick walls and mass lesions in the vicinity of the duodenum show high intensity on diffusion‐weighted images. (e) Liver SOLs also appear cystic on abdominal ultrasound. (f) Upper gastrointestinal endoscopy revealing an irregularly raised surface near the duodenal papilla. The patient underwent diagnostic biopsies from the duodenum and thick parts of the liver lesion (thick walls at the margins). Histopathology revealed complicated spindle‐shaped cells in the liver (Fig. S1A, Supporting information, hematoxylin and eosin stain; original magnification, 200×) and duodenal lesions (Fig. S1B, hematoxylin and eosin stain; original magnification, 200×). These tumors were c‐Kit‐ and CD34‐positive (Fig. S1C; liver, S1D; duodenum, original magnification, ×200), but negative for S‐100, cytokeratin AE1/AE3, and alpha‐smooth muscle actin. Mitotic rate was almost unrecognizable in the 0–1 >50 high‐power fields and showed a high Ki‐67 labeling index (>5%). There was no evidence of necrosis or neovascularization in the collected tissues.

Discussion

Liver metastases of GISTs are known to cause cystic changes following treatment, such as imatinib mesylate. However, to the best of our knowledge, only six cases of hepatic GIST with predominantly cystic changes (prior to any treatment) have been reported (Table S1). , , , , , In this case, a duodenal biopsy was initially undiagnosed; after a liver biopsy, which was performed with a risk for bleeding, we identified a GIST after examining the duodenal tissue. The unique radiological feature of this case is that there was a higher marginal attenuation area compared to that of the central area, which was different from a simple hepatic cyst. Although this case did not perform a contrast‐enhanced CT and MRI because of renal dysfunction, neovascularization of the marginal thickening area of cystic lesions might help to diagnose cystic changes in GISTs. , , This patient does not wish to receive treatment and is being followed up. It should be noted that GISTs appear predominantly cystic in all organs. Figure S1 (A; liver, B: duodenum) Histological examination with HE Staining revealed complicated spindle‐shaped cells (original magnification, ×200). (C; liver, D; duodenum) These tumors were c‐Kit‐ and CD34‐positive (original magnification, ×200). Click here for additional data file. Table S1 Cystic hepatic metastases due to gastrointestinal stromal tumors prior to any treatment. Click here for additional data file.
  7 in total

1.  Cystlike hepatic metastases from gastrointestinal stromal tumors could be seen before any treatment.

Authors:  Dimitrios Zonios; Maria Soula; Athanasios J Archimandritis; Konstantinos Revenas
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

2.  Cystic hepatic metastasis from gastrointestinal stromal tumor prior to imatinib mimicking a liver abscess.

Authors:  Pankaj Jain; Ashish Kumar Jha; Ramesh Roop Rai
Journal:  J Gastrointestin Liver Dis       Date:  2009-03       Impact factor: 2.008

Review 3.  Cystic lesions of the liver.

Authors:  Behroze Vachha; Maryellen R M Sun; Bettina Siewert; Ronald L Eisenberg
Journal:  AJR Am J Roentgenol       Date:  2011-04       Impact factor: 3.959

4.  Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden.

Authors:  Bengt Nilsson; Per Bümming; Jeanne M Meis-Kindblom; Anders Odén; Aydin Dortok; Bengt Gustavsson; Katarzyna Sablinska; Lars-Gunnar Kindblom
Journal:  Cancer       Date:  2005-02-15       Impact factor: 6.860

5.  Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (imatinib mesylate).

Authors:  Michael Y M Chen; Robert E Bechtold; Paul D Savage
Journal:  AJR Am J Roentgenol       Date:  2002-10       Impact factor: 3.959

Review 6.  Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST).

Authors:  Ying-Jiang Ye; Zhi-Dong Gao; G J Poston; Shan Wang
Journal:  Eur J Surg Oncol       Date:  2009-01-29       Impact factor: 4.424

7.  Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.

Authors:  Radoje Colović; Marjan Micev; Slavko Matić; Natasa Colović; Nikica Grubor; Henry Dushan Atkinson
Journal:  Vojnosanit Pregl       Date:  2013-02       Impact factor: 0.168

  7 in total
  1 in total

1.  High-frame-rate contrast-enhanced ultrasound findings of liver metastasis of duodenal gastrointestinal stromal tumor: A case report and literature review.

Authors:  Jia-Hui Chen; Ying Huang
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.